Waxman quoted on the impact of Expanded tPA criteria

Waxman quoted on the impact of Expanded tPA criteria
Expanded tPA Criteria Means Many More Potential Plaintiffs
April 18, 2018

David Waxman, a partner in the Firm’s Litigation Practice, is quoted in this article on the potential for medical malpractice lawsuits if a tissue plasminogen activator (tPA) isn’t administered to a stroke patient in the emergency department.

To read the full article, click here.